Core Points - Cidara Therapeutics (CDTX.US) shares surged over 105% to a new eight-year high of $217.8 following the announcement of a definitive agreement for acquisition by Merck (MRK.US) at $221.50 per share in cash [1] - The total value of the transaction is approximately $9.2 billion, and it has been approved by the boards of both companies [1] - The acquisition is subject to the approval of the Hart-Scott-Rodino Antitrust Improvements Act (HSR) and other customary closing conditions, with an expected completion in Q1 2026 [1] - Merck's President of Research Laboratories, Dr. Dean Li, stated that this acquisition enhances and expands their respiratory product portfolio and R&D pipeline [1]

Core Viewpoint - The company, Yongxi Electronics, has acquired 100% equity of Ningbo Yuchang through a public auction, ensuring transparency and utilizing self-owned and self-raised funds, without involving convertible bond financing [2] Group 1: Acquisition Details - The acquisition price was determined based on evaluations from a third-party assessment agency [2] - The core asset of the acquired company is the second-phase factory, which is also the site of the company's planned investment project of 11.1 billion yuan [2] - The second-phase factory employs an "EPC+F" construction model and was previously leased by the company [2] Group 2: Financial Impact - The acquisition will not significantly change the company's total liabilities or financial expenses, nor will it adversely affect production and operations [2] - The acquisition allows the company to gain autonomous control over key assets, which is beneficial for stabilizing the operating environment and reducing future uncertainties [2] Group 3: Strategic Alignment - The acquisition aligns with the company's strategy and will not lead to significant changes in its main business operations [2] - The company will not engage in real estate or construction businesses following this acquisition [2]

11月12日，港股耀才证券股价开盘后快速下冲，最大跌幅超过13%。随后交易时间段，公司股价开始抬 升，于收盘后录得跌幅5.28%。 耀才证券的这场股价震荡与蚂蚁集团的收购案相关。据悉，按照双方原定收购协议，交易截止日期是 2025年的11月25日，但协议的剩余完成条件可能于最终截止日期或之前未能达成，要约人正考虑可能延 长最终截止日期。 收购案起"波折" 蚂蚁集团对于耀才证券的收购案进展并没有预期的顺利。 早在4月25日，耀才证券就发布公告称，上海云进通过旗下子公司蚂蚁财富，以每股3.28港元的价格向 耀才证券发起要约收购，交易股份约为8.58亿股，占已发行股份总数的约50.55%，价格合计28.14亿港 元。倘若上述交易成功，耀才证券将成功易主，投入蚂蚁集团麾下。 10月10日晚间，上述收购案进一步推进。耀才证券发布公告称，蚂蚁集团收购耀才证券的事项已经获香 港证监会批准。目前，还需国家发展改革委审批后落定。 彼时，港股耀才证券金融（HK.01428）曾因此消息实现了一波34.52%的大幅上涨。 11月11日晚，上述收购案出现波折。耀才证券发布消息称，收购要约人蚂蚁集团方面正考虑可能延长交 易的最后截止日期 ...

Core Viewpoint - Shunlong Holdings is transferring shares worth HKD 295 million, representing 50.68% of its stock, from Emperor Securities Hong Kong to Bank of Communications International Securities [1] Group 1: Share Transfer - On November 13, Shunlong Holdings' shareholders transferred shares valued at HKD 295 million, which accounts for 50.68% of the company's stock [1] Group 2: Acquisition Announcement - Shunlong Holdings announced plans to acquire Hio Pro (Vietnam) Sporting Goods Company Limited for USD 2.5 million, which represents the entire paid-up charter capital of VND 615.20 billion [1] - The target company is a wholly foreign-owned enterprise in Vietnam, primarily engaged in the manufacturing of golf equipment and related components [1] Group 3: Strategic Rationale - The acquisition allows Shunlong Holdings to manufacture golf products in Vietnam, where export tariffs are lower than those from China, thereby alleviating tariff burdens and enhancing competitiveness in the U.S. market [1] - This strategic move aims to improve the overall operational efficiency of the group while maintaining competitiveness in the golf business [1]

Core Viewpoint - The stock price of Yao Cai Securities experienced significant volatility due to the acquisition proposal from Ant Group, with a maximum drop of over 13% before closing down 5.28% [2]. Group 1: Acquisition Details - Ant Group initiated a takeover bid for Yao Cai Securities on April 25, offering HKD 3.28 per share for approximately 858 million shares, totaling HKD 28.14 billion, which represents about 50.55% of the total issued shares [3]. - The acquisition has received approval from the Hong Kong Securities and Futures Commission, but it still requires approval from the National Development and Reform Commission [3]. - On November 11, Yao Cai Securities announced that Ant Group is considering extending the final deadline for the acquisition [5]. Group 2: Financial Performance - Yao Cai Securities reported total revenues of HKD 10.14 billion, HKD 10.50 billion, and HKD 11.21 billion for the fiscal years 2022 to 2024, with year-on-year changes of -19.96%, -4.05%, and 3.09% respectively [8]. - The net profit attributable to the parent company for the same period was HKD 4.55 billion, HKD 5.43 billion, and HKD 5.06 billion, with year-on-year changes of -20.23%, 10.53%, and -9.95% respectively [8]. Group 3: Company Background - Yao Cai Securities was founded in 1995 by Ye Maolin and offers services including Hong Kong stock trading, margin financing, securities custody, futures and options trading, leveraged forex trading, and spot gold and silver trading [8]. - The company is known for its low commission rates, having significantly reduced its commission from 0.25% to 0.05% after the government abolished the minimum commission system in 2003 [8].

11月12日，港股耀才证券股价开盘后快速下冲，最大跌幅超过13%。随后交易时间段，公司股价开始抬 升，于收盘后录得跌幅5.28%。 耀才证券的这场股价震荡与蚂蚁集团的收购案相关。据悉，按照双方原定收购协议，交易截止日期是 2025年的11月25日，但协议的剩余完成条件可能于最终截止日期或之前未能达成，要约人正考虑可能延 长最终截止日期。 收购案起"波折" 蚂蚁集团对于耀才证券的收购案进展并没有预期的顺利。 早在4月25日，耀才证券就发布公告称，上海云进通过旗下子公司蚂蚁财富，以每股3.28港元的价格向 耀才证券发起要约收购，交易股份约为8.58亿股，占已发行股份总数的约50.55%，价格合计28.14亿港 元。倘若上述交易成功，耀才证券将成功易主，投入蚂蚁集团麾下。 10月10日晚间，上述收购案进一步推进。耀才证券发布公告称，蚂蚁集团收购耀才证券的事项已经获香 港证监会批准。目前，还需国家发展改革委审批后落定。 就蚂蚁集团延长最终截止日期可能带来的影响，南都湾财社向耀才证券发送了采访函，但并未收到回 复。 耀才+蚂蚁背后有何影响？ 彼时，港股耀才证券金融（HK.01428）曾因此消息实现了一波34.52%的大 ...

Core Insights - Essity has announced the acquisition of Edgewell Feminine Care business in North America, indicating a strategic move to enhance its market position in the feminine care segment [1][2] Group 1: Acquisition Details - The acquisition aims to strengthen Essity's portfolio in the feminine care market, which is expected to provide synergies and growth opportunities [1] - The announcement was made during an audiocast led by Essity's Head of Investor Relations, Sandra Åberg, highlighting the significance of the acquisition [1] Group 2: Leadership Presentation - The presentation included insights from Essity's President and CEO, Ulrika Kolsrud, and CFO, Fredrik Rystedt, who discussed the financial implications and strategic rationale behind the acquisition [2] - Presentation materials were made available on Essity's website, ensuring transparency and accessibility for stakeholders [2]

Core Viewpoint - Feiya (000026.SZ) is advancing the acquisition of Chang Kong Gear, with ongoing audits and evaluations, but the transaction plan is not yet finalized and remains uncertain [1] Group 1 - The company is currently working on the acquisition of Chang Kong Gear [1] - Various aspects such as audits and evaluations are being conducted as part of the acquisition process [1] - There is still uncertainty regarding the finalization of the transaction plan [1]

Core Viewpoint - Ant Group is considering extending the deadline for its acquisition offer for Yao Cai Securities, originally set for November 25, 2025, as part of its strategy to gain a 50.55% stake in the company [1] Group 1 - The acquisition offer was initiated at a price of HKD 3.28 per share [1] - This acquisition is seen as a significant step for Ant Group in its efforts to enter the overseas brokerage license market [1]

Core Viewpoint - The acquisition of a 72.5% stake in Jiangxi Jiuai Food Co., Ltd. by Qian Shi International's wholly-owned subsidiary, Qiaoxiong (Fujian) Investment Co., Ltd., for HKD 59 million is seen as an attractive opportunity to enhance the company's business portfolio and benefit from the target company's profits [1] Group 1: Acquisition Details - The acquisition will be settled through the issuance of convertible bonds worth HKD 59 million at a conversion price of HKD 0.25 per share [1] - Jiangxi Jiuai Food Co., Ltd. operates a production base covering approximately 340 acres with a building area of about 147,000 square meters [1] Group 2: Target Company Overview - The target company is a leading beverage processing enterprise in Fuzhou, with five product lines under the "Aizhilian" brand, including Nanfeng honey tangerine vinegar, Nanfeng honey tangerine juice, plant protein, fermented fruit juice, and grain protein [1]